CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices

Neuropharmacology

Volumn 60, Issue 4, 2011, Pages 674-682

  Landucci, Elisa ^a   Scartabelli, Tania ^a   Gerace, Elisabetta ^a   Moroni, Flavio ^a   Pellegrini Giampietro, Domenico E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

2 Arachidonoylglycerol; Anandamide; CB1 receptors; CB2 receptors; Cerebral ischemia; Fatty acid amide hydrolase; Monoacylglycerol lipase; Organotypic hippocampal slices; Oxygen glucose deprivation; TRPV1 receptors

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; ANANDAMIDE; ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; GLUCOSE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SLICE; CAROTID ARTERY OBSTRUCTION; CELL FATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; GERBIL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; ARACHIDONIC ACIDS; BENZOXAZINES; BRAIN ISCHEMIA; CANNABINOIDS; CYCLOHEXANOLS; GERBILLINAE; GLUCOSE; HIPPOCAMPUS; MORPHOLINES; NAPHTHALENES; NEURONS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 79251598843     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.11.021     Document Type: Article

References (51)

1. D. Amantea, P. Spagnuolo, M. Bari, F. Fezza, C. Mazzei, C. Tassorelli, L.A. Morrone, M.T. Corasaniti, M. Maccarrone, and G. Bagetta Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol FEBS Journal 274 2007 4464 4775
2. J.C. Ashton, R.M. Rahman, S.M. Nair, B.A. Sutherland, M. Glass, and I. Appleton Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain Neuroscience Letters 412 2007 114 117
3. C. Berger, P.C. Schmid, W.R. Schabitz, M. Wolf, S. Schwab, and H.H. Schmid Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? Journal of Neurochemistry 88 2004 1159 1167
4. D. Braida, M. Pozzi, and M. Sala CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils Neuroscience Letters 296 2000 69 72
5. I. Cernak, R. Vink, J. Natale, B. Stoica, P.M. Lea, V. Movsesyan, F. Ahmed, S.M. Knoblach, S.T. Fricke, and A.I. Faden The "dark side" of endocannabinoids: a neurotoxic role for anandamide Journal of Cerebral Blood Flow and Metabolism 24 2004 564 578
6. G.C.K. Chan, T.R. Hinds, S. Impey, and D.R. Storm Hippocampal neurotoxicity of delta(9)-tetrahydrocannabinol Journal of Neuroscience 18 1998 5322 5332
7. A. Cozzi, E. Meli, V. Carl, F. Moroni, and D.E. Pellegrini-Giampietro Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? Neuropharmacology 43 2002 119 130
8. M. Degn, K.L. Lambertsen, G. Petersen, M. Meldgaard, A. Artmann, B.H. Clausen, S.H. Hansen, B. Finsen, H.S. Hansen, and T.M. Lund Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice Journal of Neurochemistry 103 2007 1907 1916
9. M.R. Domenici, S.C. Azad, G. Marsicano, A. Schierloh, C.T. Wotjak, H.U. Dodt, W. Zieglgansberger, B. Lutz, and G. Rammes Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission Journal of Neuroscience 26 2006 5794 5799
10. E. Downer, B. Boland, M. Fogarty, and V. Campbell Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor Neuroreport 12 2001 3973 3978
11. D. Fernandez-Lopez, J. Martinez-Orgado, E. Nunez, J. Romero, P. Lorenzo, M.A. Moro, and I. Lizasoain Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats Pediatric Research 60 2006 169 173
12. C.J. Fowler, S. Holt, O. Nilsson, K.O. Jonsson, G. Tiger, and S.O. Jacobsson The endocannabinoid signaling system: pharmacological and therapeutic aspects Pharmacology Biochemistry and Behavior 81 2005 248 262
13. A. Franklin, S. Parmentier-Batteur, L. Walter, D.A. Greenberg, and N. Stella Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility Journal of Neuroscience 23 2003 7767 7775
14. G. Gerdeman, and D.M. Lovinger CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum Journal of Neurophysiology 85 2001 468 471
15. E.R. Grant, A.E. Dubin, S.P. Zhang, R.A. Zivin, and Z. Zhong Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1)-transfected human embryonic kidney cells: a method to resolve ionic dependence of VR1-mediated cell death Journal of Pharmacology and Experimental Therapeutics 300 2002 9 17
16. N. Hajos, I. Katona, S.S. Naiem, K. Mackie, C. Ledent, I. Mody, and T.F. Freund Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations European Journal of Neuroscience 12 2000 3239 3249
17. C.J. Hillard Role of cannabinoids and endocannabinoids in cerebral ischemia Current Pharmaceutical Design 14 2008 2347 2361
18. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacological Reviews 54 2002 161 202
19. K.L. Jin, X.O. Mao, P.C. Goldsmith, and D.A. Greenberg CB1 cannabinoid receptor induction in experimental stroke Annals of Neurology 48 2000 257 261
20. I. Katona, B. Sperlagh, A. Sik, A. Kafalvi, E.S. Vizi, K. Mackie, and T.F. Freund Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons Journal of Neuroscience 19 1999 4544 4558
21. P.W. Landfield, L.B. Cadwallader, and S. Vinsant Quantitative changes in hippocampal structure following long-term exposure to delta 9- tetrahydrocannabinol: possible mediation by glucocorticoid systems Brain Research 443 1988 47 62
22. E. Landucci, F. Boscia, E. Gerace, T. Scartabelli, A. Cozzi, F. Moroni, G. Mannaioni, and D.E. Pellegrini-Giampietro Involvement of endocannabinoid signaling in the neuroprotective effects of subtype I metabotropic glutamate receptor antagonists in models of cerebral ischemia International Review of Neurobiology 85 2009 337 350
23. D.F. Louw, F.W. Yang, and G.R. Sutherland The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat Brain Research 857 2000 183 187
24. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors - evidence for a protective role of cannabinoid receptors Journal of Biological Chemistry 275 2000 31938 31945
25. K. Maresz, E.J. Carrier, E.D. Ponomarev, C.J. Hillard, and B.N. Dittel Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli Journal of Neurochemistry 95 2005 437 445
26. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutierrez, M. van der Stelt, M.L. Lopez-Rodriguez, E. Casanova, G. Schutz, W. Zieglgansberger, V. Di Marzo, C. Behl, and B. Lutz CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
27. G. Marsicano, B. Moosmann, H. Hermann, B. Lutz, and C. Behl Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1 Journal of Neurochemistry 80 2002 448 456
28. F. Mauler, V. Hinz, K.H. Augstein, M. Fassbender, and E. Horvath Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271 Brain Research 989 2003 99 111
29. M. Melis, G. Pillola, T. Bisogno, A. Minassi, S. Petrosino, S. Perra, A.L. Muntoni, B. Lutz, G.L. Gessa, G. Marsicano, V. Di Marzo, and M. Pistis Protective activation of the endocannabinoid system during ischemia in dopamine neurons Neurobiology of Disease 24 2006 15 27
30. K. Monory, F. Massa, M. Egertova, M. Eder, H. Blaudzun, R. Westenbroek, W. Kelsch, W. Jacob, R. Marsch, M. Ekker, J. Long, J.L. Rubenstein, S. Goebbels, K.A. Nave, M. During, M. Klugmann, B. Wolfel, H.U. Dodt, W. Zieglgansberger, C.T. Wotjak, K. Mackie, M.R. Elphick, G. Marsicano, and B. Lutz The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron 51 2006 455 466
31. F. Moroni, S. Attucci, A. Cozzi, E. Meli, R. Picca, M.A. Scheideler, R. Pellicciari, C. Noe, I. Sarichelou, and D.E. Pellegrini-Giampietro The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death Neuropharmacology 42 2002 741 751
32. F. Moroni, E. Meli, F. Peruginelli, A. Chiarugi, A. Cozzi, R. Picca, P. Romagnoli, R. Pellicciari, and D.E. Pellegrini-Giampietro Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia Cell Death and Differentiation 8 2001 921 932
33. S. Muthian, D.J. Rademacher, C.T. Roelke, G.J. Gross, and C.J. Hillard Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia Neuroscience 129 2004 743 750
34. T. Nagayama, A.D. Sinor, R.P. Simon, J. Chen, S.H. Graham, K. Jin, and D.A. Greenberg Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures Journal of Neuroscience 19 1999 2987 2995
35. B. Nemeth, C. Ledent, T.F. Freund, and N. Hajos CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2 Neuropharmacology 54 2008 51 57
36. P. Pacher, and G. Hasko Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning British Journal of Pharmacology 153 2008 252 262
37. D. Panikashvili, C. Simeonidou, S. Ben Shabat, L. Hanus, A. Breuer, R. Mechoulam, and E. Shohami An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531
38. S. Parmentier-Batteur, K. Jin, X.O. Mao, L. Xie, and D.A. Greenberg Increased severity of stroke in CB1 cannabinoid receptor knock-out mice Journal of Neuroscience 22 2002 9771 9775
39. S. Pegorini, A. Zani, D. Braida, C. Guerini-Rocco, and M. Sala Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection British Journal of Pharmacology 147 2006 552 559
40. D.E. Pellegrini-Giampietro The distinct role of mGlu1 receptors in post-ischemic neuronal death Trends in Pharmacological Sciences 24 2003 461 470
41. D.E. Pellegrini-Giampietro, A. Cozzi, F. Peruginelli, P. Leonardi, E. Meli, R. Pellicciari, and F. Moroni 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3′-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia European Journal of Neuroscience 11 1999 3637 3647
42. D.E. Pellegrini-Giampietro, G. Mannaioni, and G. Bagetta The endocannabinoid system in the mechanisms of post-ischemic neuronal death FEBS Journal 276 2009 2 12
43. D.E. Pellegrini-Giampietro, F. Peruginelli, E. Meli, A. Cozzi, S. Albani Torregrossa, R. Pellicciari, and F. Moroni Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms Neuropharmacology 38 1999 1607 1619
44. D. Piomelli The molecular logic of endocannabinoid signalling Nature Reviews Neuroscience 4 2003 873 884
45. A.C. Scallet Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals Pharmacology Biochemistry and Behavior 40 1991 671 676
46. W.R. Schabitz, A. Giuffrida, C. Berger, A. Aschoff, M. Schwaninger, S. Schwab, and D. Piomelli Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study Stroke 33 2002 2112 2114
47. A.D. Sinor, S.M. Irvin, and D.A. Greenberg Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats Neuroscience Letters 278 2000 157 160
48. C. Sommer, M. Schomacher, C. Berger, K. Kuhnert, H.D. Muller, S. Schwab, and W.R. Schabitz Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra Acta Neuropathologica 112 2006 277 286
49. M. van der Stelt, and V. Di Marzo Cannabinoid receptors and their role in neuroprotection Neuromolecular Medicine 7 2005 37 50
50. C.G. Werner, T. Scartabelli, T. Pancani, E. Landucci, F. Moroni, and D.E. Pellegrini-Giampietro Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance European Journal of Neuroscience 25 2007 3597 3604
51. M. Zhang, B.R. Martin, M.W. Adler, R.K. Razdan, D. Ganea, and R.F. Tuma Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury Neuroscience 152 2008 753 760